Role of Vitamin D in Parkinson’s Disease

admin
March 8, 2026

This eBook from Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Julissa Clay , Shelly Manning , Jodi Knapp and Scott Davis.

The Parkinson’s Protocol By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

Role of Vitamin D in Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a deficiency of dopamine in the brain. It manifests with motor symptoms such as tremor, bradykinesia, rigidity, and postural instability, as well as non-motor symptoms including cognitive decline, depression, sleep disturbances, and gastrointestinal dysfunction. While the precise cause of PD remains unclear, both genetic and environmental factors contribute to its development and progression.

In recent years, Vitamin D has gained attention as a potential factor influencing Parkinson’s disease. Traditionally recognized for its role in bone health, calcium regulation, and immune function, Vitamin D has increasingly been studied for its broader effects on the brain, including neuroprotection, regulation of neurotransmitters, and modulation of inflammation. Research suggests that Vitamin D deficiency is common in individuals with PD and may be linked to worse outcomes, including increased risk of falls, cognitive impairment, and disease progression.

This essay explores the role of Vitamin D in Parkinson’s disease, including its physiological functions, prevalence of deficiency in PD patients, possible mechanisms of action, evidence from clinical studies, and implications for treatment and management.

1. Physiological Functions of Vitamin D

Vitamin D is a fat-soluble vitamin obtained through sunlight exposure, diet, and supplementation. Once synthesized in the skin or ingested, it undergoes hydroxylation in the liver to form 25-hydroxyvitamin D [25(OH)D], the main circulating form, and subsequently in the kidneys to produce the active hormone 1,25-dihydroxyvitamin D [1,25(OH)â‚‚D].

Key physiological roles include:

  1. Bone and Calcium Homeostasis – Vitamin D regulates calcium and phosphate metabolism, ensuring proper bone mineralization.

  2. Immune Regulation – It modulates immune responses, reducing pro-inflammatory cytokines and supporting anti-inflammatory pathways.

  3. Neurological Functions – Vitamin D receptors (VDRs) and the enzyme 1-alpha-hydroxylase are widely expressed in the brain, including the substantia nigra, hippocampus, and cortex. This suggests that Vitamin D influences neuronal health, neurotransmission, and neuroprotection.

  4. Antioxidant Activity – Vitamin D may counter oxidative stress, which plays a key role in neurodegeneration.

2. Prevalence of Vitamin D Deficiency in Parkinson’s Disease

Several studies have reported a high prevalence of Vitamin D deficiency in PD patients compared to age-matched controls. Factors contributing to deficiency include:

  • Reduced Sunlight Exposure – Many PD patients have decreased mobility, leading to less time outdoors.

  • Aging – Older adults have reduced capacity for skin synthesis of Vitamin D.

  • Dietary Limitations – Poor appetite or difficulty swallowing may limit intake of Vitamin D-rich foods.

  • Medication Interactions – Some PD medications and comorbid treatments may interfere with Vitamin D metabolism.

  • Disease-Related Changes – The neurodegenerative process itself may alter Vitamin D metabolism.

Low Vitamin D levels in PD patients have been associated with greater disease severity, increased risk of falls, impaired balance, and cognitive decline.

3. Mechanisms Linking Vitamin D to Parkinson’s Disease

A. Neuroprotection

Vitamin D promotes neuronal survival by regulating neurotrophic factors such as nerve growth factor (NGF) and glial cell-derived neurotrophic factor (GDNF), both of which support dopaminergic neurons.

B. Regulation of Dopamine

Vitamin D influences dopamine synthesis by modulating the expression of tyrosine hydroxylase, the rate-limiting enzyme in dopamine production.

C. Anti-Inflammatory Effects

Neuroinflammation is a hallmark of PD. Vitamin D reduces pro-inflammatory cytokines such as TNF-alpha and interleukin-6 while enhancing anti-inflammatory pathways, potentially reducing neurodegeneration.

D. Antioxidant Defense

Oxidative stress contributes to dopaminergic cell death. Vitamin D enhances antioxidant defenses by increasing glutathione production and reducing reactive oxygen species (ROS).

E. Bone Health and Falls

PD patients are prone to falls due to motor symptoms. Vitamin D deficiency exacerbates osteoporosis and muscle weakness, increasing the risk of fractures and disability.

F. Cognitive Function

Vitamin D receptors in the hippocampus suggest a role in memory and cognition. Deficiency has been linked to cognitive decline and dementia in PD patients.

4. Evidence from Clinical Studies

A. Observational Studies

Many cross-sectional and longitudinal studies have found lower Vitamin D levels in PD patients compared to controls.

  • A Japanese study reported that Vitamin D deficiency correlated with increased severity of motor symptoms.

  • U.S. studies showed that PD patients with higher Vitamin D levels had better cognitive performance.

B. Interventional Studies

  • Randomized Controlled Trials (RCTs): Some RCTs have tested Vitamin D supplementation in PD patients. For example, one study showed that Vitamin D supplementation (1200 IU/day) slowed disease progression in patients carrying specific genetic variants of the VDR gene.

  • Fall Prevention: Supplementation has been associated with improved balance and reduced fall risk in PD, although results are mixed.

  • Cognition: Trials indicate that supplementation may improve certain aspects of cognitive performance, but more evidence is needed.

C. Meta-Analyses

Recent meta-analyses confirm that PD patients generally have lower Vitamin D levels than controls, and supplementation may provide modest improvements in motor and non-motor symptoms. However, the data remain heterogeneous, highlighting the need for more large-scale studies.

5. Genetic Factors and Vitamin D Receptor (VDR) Polymorphisms

Genetic variations in the Vitamin D receptor (VDR) gene may influence susceptibility to PD and responsiveness to Vitamin D supplementation.

  • Certain polymorphisms (e.g., FokI, BsmI, TaqI, ApaI) have been linked to either increased or decreased PD risk.

  • VDR polymorphisms may also explain why some individuals respond better to supplementation than others.

6. Implications for Clinical Management

A. Screening

  • Routine screening for Vitamin D deficiency is recommended in PD patients, especially those with advanced disease, limited mobility, or frequent falls.

  • Serum 25(OH)D levels should be measured to guide supplementation.

B. Supplementation

  • The optimal dosage remains debated, but 800–2000 IU/day is often recommended for older adults and those deficient.

  • Supplements should be tailored to individual needs, with monitoring to avoid toxicity (hypercalcemia).

C. Dietary Sources

  • Vitamin D-rich foods include fatty fish (salmon, mackerel, sardines), fortified dairy products, egg yolks, and mushrooms.

  • Adequate calcium intake should accompany Vitamin D to support bone health.

D. Sunlight Exposure

  • Safe and regular exposure to sunlight (10–30 minutes several times per week) can help maintain Vitamin D levels, though this may be limited for PD patients with reduced mobility.

E. Multidisciplinary Care

  • Collaboration between neurologists, dietitians, physiotherapists, and caregivers ensures that Vitamin D management is integrated into overall care.

7. Limitations and Future Research

Despite promising evidence, several gaps remain:

  • Causality: It is unclear whether Vitamin D deficiency contributes to PD onset or is a consequence of the disease.

  • Optimal Levels: The exact serum Vitamin D level needed for neuroprotection in PD is not established.

  • Dose-Response Relationship: More trials are needed to determine the ideal dosage and duration of supplementation.

  • Individual Variability: Genetic differences, lifestyle, and comorbidities may influence outcomes.

  • Combination Therapies: Research should explore whether Vitamin D works synergistically with pharmacological or lifestyle interventions.

Future studies should focus on long-term randomized controlled trials assessing the effects of Vitamin D supplementation on motor progression, non-motor symptoms, cognition, and quality of life in PD.

Conclusion

Vitamin D plays a multifaceted role in Parkinson’s disease, extending beyond its traditional function in bone health to encompass neuroprotection, dopamine regulation, anti-inflammatory action, and antioxidant defense. Deficiency is common among PD patients, likely due to reduced mobility, aging, and disease-related factors. Evidence suggests that low Vitamin D levels are associated with worse motor and non-motor outcomes, including increased falls, cognitive decline, and possibly faster disease progression.

While clinical trials provide some support for supplementation, results remain mixed, underscoring the need for more robust research. Nevertheless, screening for deficiency and providing individualized supplementation is a reasonable and low-risk strategy in PD management, particularly given the high risk of osteoporosis and falls in this population.

In the broader picture, Vitamin D may serve as both a biomarker and therapeutic target in PD. Optimizing Vitamin D status through diet, supplementation, and safe sun exposure should be viewed as part of a comprehensive, multidisciplinary approach to Parkinson’s disease care.

The Parkinson’s Protocol By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

This eBook from Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Julissa Clay , Shelly Manning , Jodi Knapp and Scott Davis.
Mr.Hotsia

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way.I share my experiences on www.hotsia.com